Par-4 prevents breast cancer recurrence

Nikhil Hebbar; Tripti Shrestha-Bhattarai; Vivek M. Rangnekar

doi:10.1186/bcr3562

Par-4 prevents breast cancer recurrence

Nikhil Hebbar
, Tripti Shrestha-Bhattarai
, Vivek M. Rangnekar

Producción científica: Article › revisión exhaustiva

2 Citas (Scopus)

Resumen

Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

Idioma original	English
Número de artículo	314
Publicación	Breast Cancer Research
Volumen	15
N.º	5
DOI	https://doi.org/10.1186/bcr3562
Estado	Published - oct 25 2013

Nota bibliográfica

Funding Information:
This work was supported by National Cancer Institute/National Institutes of Health grant CA060872 and Kentucky Lung Cancer Research grant (to VMR).

Financiación

This work was supported by National Cancer Institute/National Institutes of Health grant CA060872 and Kentucky Lung Cancer Research grant (to VMR).

Financiadores	Número del financiador
Kentucky Lung Cancer Research Association
National Institutes of Health (NIH)
National Childhood Cancer Registry – National Cancer Institute	R01CA060872

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

Oncology
Cancer Research

Acceder al documento

10.1186/bcr3562

Otros archivos y enlaces

Citar esto

@article{2a2e8cd3edc9435ea8b158bb5cf8d2a0,

title = "Par-4 prevents breast cancer recurrence",

abstract = "Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.",

author = "Nikhil Hebbar and Tripti Shrestha-Bhattarai and Rangnekar, \{Vivek M.\}",

note = "Funding Information: This work was supported by National Cancer Institute/National Institutes of Health grant CA060872 and Kentucky Lung Cancer Research grant (to VMR).",

year = "2013",

month = oct,

day = "25",

doi = "10.1186/bcr3562",

language = "English",

volume = "15",

number = "5",

}

TY - JOUR

T1 - Par-4 prevents breast cancer recurrence

AU - Hebbar, Nikhil

AU - Shrestha-Bhattarai, Tripti

AU - Rangnekar, Vivek M.

N1 - Funding Information: This work was supported by National Cancer Institute/National Institutes of Health grant CA060872 and Kentucky Lung Cancer Research grant (to VMR).

PY - 2013/10/25

Y1 - 2013/10/25

N2 - Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

AB - Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

UR - https://www.scopus.com/pages/publications/84887511091

UR - https://www.scopus.com/pages/publications/84887511091#tab=citedBy

U2 - 10.1186/bcr3562

DO - 10.1186/bcr3562

M3 - Article

C2 - 24164776

AN - SCOPUS:84887511091

SN - 1465-5411

VL - 15

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 5

M1 - 314

ER -

Par-4 prevents breast cancer recurrence

Resumen

Nota bibliográfica

Financiación

ODS de las Naciones Unidas

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto